Comments regarding 'A randomised placebo-controlled double-blind trial to evaluate lipid-lowering pharmacotherapy on proteolysis and inflammation in abdominal aortic aneurysms'.
Vega de Céniga
M
M
Department of Angiology and Vascular Surgery, Hospital de Galdakao-Usansolo, Barrio Labeaga s/n, 48960 Galdakao, Bizkaia, Spain.
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001012:Aorta, Abdominal / Q000378:metabolism* / Q000473:pathology / Q000601:surgery; D017544:Aortic Aneurysm, Abdominal / Q000628:therapy*; D001384:Azetidines / Q000627:therapeutic use; D001706:Biopsy; D004359:Drug Therapy, Combination; D000069438:Ezetimibe; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism*; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism*; D016032:Randomized Controlled Trials as Topic; D019821:Simvastatin / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D001384:Azetidines; D015850:Interleukin-6; D019821:Simvastatin; D020780:Matrix Metalloproteinase 9; D000069438:Ezetimibe